Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso
Clinical trial NCT02663700 · COMPLETED
Trial details
- NCT number
- NCT02663700
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-07
- Primary completion
- 2018-12-17
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.